Clinical trial
Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
NCT00619775 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial
- Lead sponsor
- Medtronic Endovascular
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- October 31, 2005
- Enrollment
- 419 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.
carotid artery disease